Press Release Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies Aug 17
Press Release Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results Aug 13